VRTX Earnings
Vertex Pharmaceuticals Inc. next reports earnings on August 3, 2026. Track record: 3/4 beats.
Next Earnings In
Monday, August 3, 2026
Current Price
$477.10
EPS Estimate
Earnings Per Share
$4.75
+5.0% YoY
Trailing EPS
Last 12 months earnings
$16.84
Beat Rate
3/4
75%Forward P/E
Price-to-Earnings ratio
22.4
Margin: 35.5%
Analyst Rating
23 analysts
Analyst Sentiment
Buy23 analystsEarnings History
| Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| 2026-03-31 | $4.31 | $4.47 | +3.8% | Beat |
| 2025-12-31 | $5.15 | $5.03 | -2.3% | Miss |
| 2025-09-30 | $4.58 | $4.80 | +4.9% | Beat |
| 2025-06-30 | $4.25 | $4.52 | +6.3% | Beat |
Growth Estimates
| Period | EPS Est. | Revenue Est. | Growth |
|---|---|---|---|
| Current Qtr(0q) | $4.75 | $3.2B | +5.0% |
| Next Qtr(+1q) | $4.81 | $3.4B | +0.3% |
| Current Year(0y) | $18.96 | $13B | +3.1% |
| Next Year(+1y) | $21.31 | $14.3B | +12.4% |
Next Quarter Estimates
EPS Estimate
Earnings Per Share
$4.75
Revenue Estimate
$3.2B
Annual EPS Est.
$18.96
+3.1% YoY
VRTX Earnings FAQ
When is VRTX's next earnings date?
Vertex Pharmaceuticals Inc. (VRTX) is expected to report earnings on August 3, 2026. The consensus EPS estimate is $4.75.
Does VRTX usually beat earnings estimates?
Vertex Pharmaceuticals Inc. has beaten Wall Street EPS estimates in 3 of the last 4 quarters (75% beat rate).
What is VRTX's trailing EPS?
Vertex Pharmaceuticals Inc.'s trailing twelve-month EPS is $16.84. This is calculated from the last four quarters of reported earnings.
What do analysts think about VRTX?
23 Wall Street analysts cover Vertex Pharmaceuticals Inc.. The consensus rating is "Buy" with an average price target of $554.91, implying 16.3% upside from the current price.